Drug Shortage Report for AUBAGIO
Report ID | 159348 |
Drug Identification Number | 02416328 |
Brand name | AUBAGIO |
Common or Proper name | Teriflunomide tablets 14 mg |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | TERIFLUNOMIDE |
Strength(s) | 14MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 14 mg |
ATC code | L04AA |
ATC description | IMMUNOSUPPRESSANTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2022-04-28 |
Actual start date | |
Estimated end date | 2022-05-11 |
Actual end date | 2022-05-03 |
Shortage status | Resolved |
Updated date | 2022-05-04 |
Company comments | Manufacturing delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-05-04 | French | Compare |
v4 | 2022-05-04 | English | Compare |
v3 | 2022-04-29 | English | Compare |
v2 | 2022-04-25 | French | Compare |
v1 | 2022-04-25 | English | Compare |
Showing 1 to 5 of 5